KOLAROVA I[au] - Search Results

Year	Number of Results
1978	2
1981	1
1998	2
2002	1
2004	1
2009	2
2010	2
2011	1
2012	2
2013	3
2014	1
2018	1
2019	4
2020	5
2021	3
2022	3
2023	1
2024	2

1

Editorial: Hematophagous arthropod saliva: a multifunctional tool.

Gomes R, Kolářová I, Sá-Nunes A, Carneiro M. Gomes R, et al. Among authors: kolarova i. Front Cell Infect Microbiol. 2022 Jul 13;12:977511. doi: 10.3389/fcimb.2022.977511. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35909959 Free PMC article. No abstract available.

2

Special Techniques of Adjuvant Breast Carcinoma Radiotherapy.

Kolářová I, Melichar B, Vaňásek J, Sirák I, Petera J, Horáčková K, Pohanková D, Šinkorová Z, Hošek O, Vošmik M. Kolářová I, et al. Cancers (Basel). 2022 Dec 31;15(1):298. doi: 10.3390/cancers15010298. Cancers (Basel). 2022. PMID: 36612294 Free PMC article. Review.

3

Parasitic Protists: Diversity of Adaptations to a Parasitic Lifestyle.

Kolářová I, Florent I, Valigurová A. Kolářová I, et al. Microorganisms. 2022 Aug 3;10(8):1560. doi: 10.3390/microorganisms10081560. Microorganisms. 2022. PMID: 36013978 Free PMC article.

4

Hide-and-Seek: A Game Played between Parasitic Protists and Their Hosts.

Kolářová I, Valigurová A. Kolářová I, et al. Microorganisms. 2021 Nov 25;9(12):2434. doi: 10.3390/microorganisms9122434. Microorganisms. 2021. PMID: 34946036 Free PMC article. Review.

5

Unrevealing the Mystery of Latent Leishmaniasis: What Cells Can Host Leishmania?

Valigurová A, Kolářová I. Valigurová A, et al. Among authors: kolarova i. Pathogens. 2023 Feb 3;12(2):246. doi: 10.3390/pathogens12020246. Pathogens. 2023. PMID: 36839518 Free PMC article. Review.

6

The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer.

Kolářová I, Melichar B, Sirák I, Vaňásek J, Petera J, Horáčková K, Pohanková D, Ďatelinka F, Šinkorová Z, Vošmik M. Kolářová I, et al. Curr Oncol. 2024 Feb 24;31(3):1207-1220. doi: 10.3390/curroncol31030090. Curr Oncol. 2024. PMID: 38534923 Free PMC article. Review.

7

Is There a Benefit of HER2-Positive Breast Cancer Subtype Determination in Clinical Practice?

Kolářová I, Vaňásek J, Odrážka K, Dušek L, Šinkorová Z, Hlávka A, Štuk J, Stejskal J, Dvořáková D, Sákra L, Mergancová J, Vilasová Z. Kolářová I, et al. Klin Onkol. 2019 Winter;32(1):25-30. doi: 10.14735/amko2019. Klin Onkol. 2019. PMID: 30764626 Review. English.

8

Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer.

Kolarova I, Vanasek J, Odrazka K, Melichar B, Ryska A, Petera J, Vosmik M, Dolezel M. Kolarova I, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Dec;163(4):285-292. doi: 10.5507/bp.2019.060. Epub 2019 Dec 11. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019. PMID: 31831888 Free article. Review.

9

Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients.

Kolarova I, Melichar B, Vanasek J, Ryska A, Horackova K, Petera J, Vosmik M, Sirak I, Dolezel M. Kolarova I, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Mar;165(1):19-25. doi: 10.5507/bp.2021.007. Epub 2021 Feb 4. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021. PMID: 33542544 Free article. Review.

10

Antineutrophil cytoplasmic antibodies in children.

Sedivá A, Kolárová I, Bartůnková J. Sedivá A, et al. Among authors: kolarova i. Eur J Pediatr. 1998 Dec;157(12):987-91. doi: 10.1007/s004310050983. Eur J Pediatr. 1998. PMID: 9877037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year